Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
PATH Stock Forecast 2026-2027
$12.03
Current Price
$6.23B
Market Cap
Buy 3
Hold 16
Sell 1
Wall St Analyst Ratings
Distance to PATH Price Targets
+41.3%
To High Target of $17.00
+8.1%
To Median Target of $13.00
-8.7%
To Low Target of $10.98
PATH Price Momentum
+3.0%
1 Week Change
+17.6%
1 Month Change
-2.4%
1 Year Change
-26.6%
Year-to-Date Change
-39.4%
From 52W High of $19.84
+30.8%
From 52W Low of $9.20
📊 TOP ANALYST CALLS
Did PATH Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if UiPath is one of their latest high-conviction picks.
Latest PATH Stock Price Targets & Analyst Predictions
Based on our analysis of 6 Wall Street analysts, PATH has a neutral consensus with a median price target of $13.00 (ranging from $10.98 to $17.00). The overall analyst rating is Buy (6.4/10). Currently trading at $12.03, the median forecast implies a 8.1% upside. This outlook is supported by 3 Buy, 16 Hold, and 1 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
PATH Analyst Ratings
3
Buy
16
Hold
1
Sell
PATH Price Target Range
Low
$10.98
Average
$13.00
High
$17.00
Current: $12.03
Latest PATH Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for PATH.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jun 29, 2026 | UBS | Radi Sultan | Neutral | Maintains | $12.00 |
| Jun 1, 2026 | BMO Capital | Market Perform | Maintains | $N/A | |
| May 29, 2026 | DA Davidson | Neutral | Maintains | $N/A | |
| May 29, 2026 | B of A Securities | Underperform | Maintains | $N/A | |
| May 29, 2026 | Morgan Stanley | Equal-Weight | Maintains | $N/A | |
| May 29, 2026 | Needham | Buy | Reiterates | $N/A | |
| Mar 16, 2026 | BMO Capital | Market Perform | Maintains | $N/A | |
| Mar 12, 2026 | UBS | Neutral | Maintains | $N/A | |
| Mar 12, 2026 | Canaccord Genuity | Buy | Maintains | $N/A | |
| Mar 12, 2026 | Truist Securities | Hold | Maintains | $N/A | |
| Mar 12, 2026 | TD Cowen | Hold | Maintains | $N/A | |
| Mar 12, 2026 | B of A Securities | Underperform | Maintains | $N/A | |
| Mar 12, 2026 | DA Davidson | Neutral | Maintains | $N/A | |
| Mar 12, 2026 | Wells Fargo | Equal-Weight | Maintains | $N/A | |
| Mar 12, 2026 | Mizuho | Neutral | Maintains | $N/A | |
| Mar 12, 2026 | Morgan Stanley | Equal-Weight | Maintains | $N/A | |
| Mar 12, 2026 | Needham | Buy | Upgrade | $N/A | |
| Jan 12, 2026 | Barclays | Equal-Weight | Maintains | $N/A | |
| Jan 5, 2026 | RBC Capital | Sector Perform | Maintains | $N/A | |
| Dec 10, 2025 | RBC Capital | Sector Perform | Maintains | $N/A |
Uipath Inc. (PATH) Competitors
The following stocks are similar to UiPath based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Uipath Inc. (PATH) Financial Data
Uipath Inc. has a market capitalization of $6.23B with a P/E ratio of 19.9x. The company generates $1.67B in trailing twelve-month revenue with a 19.6% profit margin.
Revenue growth is +17.3% quarter-over-quarter, while maintaining an operating margin of +7.3% and return on equity of +18.2%.
Valuation Metrics
Market Cap
$6.23B
Enterprise Value
$4.97B
P/E Ratio
19.9x
PEG Ratio
-0.1x
Price/Sales
3.7x
Growth & Margins
Revenue Growth (YoY)
+17.3%
Gross Margin
+81.6%
Operating Margin
+7.3%
Net Margin
+19.6%
EPS Growth
+17.3%
Financial Health
Cash/Price Ratio
+21.0%
Current Ratio
2.3x
Debt/Equity
4.4x
ROE
+18.2%
ROA
+2.4%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Uipath Inc. (PATH) Business Model
About Uipath Inc.
What They Do
Enterprise software solutions for automation.
Business Model
UiPath generates revenue by offering automation solutions, primarily through its robotic process automation (RPA) platform. The company provides both cloud-based and on-premises software licenses, along with support services, targeted at various sectors such as financial services, healthcare, and manufacturing. By integrating advanced technologies like AI and machine learning, UiPath enhances its offerings, allowing businesses to streamline operations and improve productivity.
Additional Information
Founded in 2005 and headquartered in New York, UiPath has positioned itself as a leader in the automation space. The platform's low-code interface caters to a diverse user base, enabling both technical and non-technical users to create and manage automations easily. The company's focus on governance and security makes it a suitable choice for large and regulated organizations, contributing to its relevance in the ongoing digital transformation journey.
Company Information
Sector
Technology
Industry
Software - Infrastructure
Employees
3,981
CEO
Mr. Daniel Solomon Dines
Country
United States
IPO Year
2021
Website
www.uipath.comUipath Inc. (PATH) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Is UiPath's 6-Month Pullback Creating an Investment Opportunity?
PATH's six-month pullback comes as AI adoption, enterprise customer growth and profitability improve, creating a more attractive entry point.
Jul 13, 2026
By Shuvra Shankar Dey
Analyst Blog
Why UiPath (PATH) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Jul 13, 2026
By Zacks Equity Research
Tale of the Tape
UiPath (PATH) Stock Declines While Market Improves: Some Information for Investors
In the closing of the recent trading day, UiPath (PATH) stood at $11.68, denoting a -1.02% move from the preceding trading day.
Jul 10, 2026
By Zacks Equity Research
Tale of the Tape
Latest News
Quick Summary
Zebra Technology's stock has risen over 11% this year, while UiPath has demonstrated profitability.
Why It Matters
Zebra Technology's 11% stock increase signals strong performance, attracting investor interest. UiPath's profitability indicates solid business health, enhancing investor confidence in tech stocks.
Source: The Motley Fool
Market Sentiment:
Positive
Quick Summary
UiPath is rated a buy at $12, with FY2027 earnings at 15x and FY2028 at 13x. Q1 FY2027 revenue grew 17% to $418M; ARR rose 12% to $1.9B. Gross margins exceed 80%.
Why It Matters
UiPath's strong revenue growth, high gross margins, and buy rating indicate potential value. However, unproven AI monetization and low net retention may pose risks to future performance.
Source: Seeking Alpha
Market Sentiment:
Positive
Quick Summary
Zacks Style Scores can assist investors in selecting strong stocks that may outperform the market for their investment portfolios.
Why It Matters
Zacks Style Scores can help identify high-potential stocks, enhancing portfolio performance and guiding investment decisions in a competitive market.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
PATH has experienced a six-month pullback, coinciding with improved AI adoption, enterprise customer growth, and profitability, presenting a potentially attractive entry point for investors.
Why It Matters
PATH's pullback alongside improving AI adoption and profitability signals a potential buying opportunity, suggesting future growth and increased shareholder value.
Source: Zacks Investment Research
Market Sentiment:
Neutral
Quick Summary
Short-interest in mid- and large-cap stocks is increasing, indicating strong bearish bets. These stocks may become candidates for significant price volatility or short squeezes.
Why It Matters
Increased bearish bets on mid- and large-cap stocks signal potential for short squeezes, which can lead to rapid price increases, presenting high-risk, high-reward trading opportunities.
Source: Benzinga
Market Sentiment:
Positive
Quick Summary
Zacks Style Scores help investors identify top-rated stocks tailored to their investing style, providing a useful tool for stock selection.
Why It Matters
Zacks Style Scores provide a systematic approach to identify high-potential stocks, enhancing investment strategies and improving portfolio performance.
Source: Zacks Investment Research
Market Sentiment:
Positive
Frequently Asked Questions About PATH Stock
What is Uipath Inc.'s (PATH) stock forecast for 2027?
Based on our analysis of 6 Wall Street analysts, Uipath Inc. (PATH) has a median price target of $13.00. The highest price target is $17.00 and the lowest is $10.98.
Is PATH stock a good investment in 2027?
According to current analyst ratings, PATH has 3 Buy ratings, 16 Hold ratings, and 1 Sell ratings. The stock is currently trading at $12.03. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for PATH stock?
Wall Street analysts predict PATH stock could reach $13.00 in the next 12 months. This represents a 8.1% increase from the current price of $12.03. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Uipath Inc.'s business model?
UiPath generates revenue by offering automation solutions, primarily through its robotic process automation (RPA) platform. The company provides both cloud-based and on-premises software licenses, along with support services, targeted at various sectors such as financial services, healthcare, and manufacturing. By integrating advanced technologies like AI and machine learning, UiPath enhances its offerings, allowing businesses to streamline operations and improve productivity.
What is the highest forecasted price for PATH Uipath Inc.?
The highest price target for PATH is $17.00 from at , which represents a 41.3% increase from the current price of $12.03.
What is the lowest forecasted price for PATH Uipath Inc.?
The lowest price target for PATH is $10.98 from at , which represents a -8.7% decrease from the current price of $12.03.
What is the overall PATH consensus from analysts for Uipath Inc.?
The overall analyst consensus for PATH is neutral. Out of 6 Wall Street analysts, 3 rate it as Buy, 16 as Hold, and 1 as Sell, with a median price target of $13.00.
How accurate are PATH stock price projections?
Stock price projections, including those for Uipath Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: July 17, 2026 4:41 PM UTC